Literature DB >> 10719243

Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway.

Y Dang1, W E Dale, O R Brown.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) reacts with either oxygen or superoxide and tryptophan (trp) or other indoleamines while tryptophan 2,3-dioxygenase (TDO) reacts with oxygen and is specific for trp. These enzymes catalyze the rate-limiting step in the kynurenine (KYN) pathway from trp to quinolinic acid (QA) with TDO in kidney and liver and IDO in many tissues, including brain where it is low but inducible. QA, which does not cross the blood-brain barrier, is an excitotoxin found in the CNS during various pathologies and is associated with convulsions. We proposed that HBO-induced convulsions result from increased flux through the KYN pathway via oxygen stimulation of IDO. To test this, TDO and IDO of liver and brain, respectively, of Sprague Dawley rats were assayed with oxygen from 0 to 6.2 atm HBO. TDO activity was appreciable at even 30 microM oxygen and rose steeply to a maximum at 40 microM. Conversely, IDO had almost no detectable activity at or below 100 microM oxygen and maximum activity was not reached until about 1150 microM. (Plasma contains about 215 microM oxygen and capillaries about 20 microM oxygen when rats breathe air.) KYN was 60% higher in brains of HBO-convulsed rats compared to rats breathing air. While the oxygen concentration inside cells of rats breathing air or HBO is not known precisely, it is clear that the rate-limiting, IDO-catalyzed step in the brain KYN pathway (but not liver TDO) can be greatly accelerated in rats breathing HBO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719243     DOI: 10.1016/s0891-5849(99)00272-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  18 in total

1.  A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Herbert L Bonkovsky; Richard Feinn; Christine Abreu; Richard K Sterling; Robert J Fontana; Henry R Kranzler
Journal:  Psychosomatics       Date:  2010 Mar-Apr       Impact factor: 2.386

2.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

Review 3.  Kynurenines in the mammalian brain: when physiology meets pathology.

Authors:  Robert Schwarcz; John P Bruno; Paul J Muchowski; Hui-Qiu Wu
Journal:  Nat Rev Neurosci       Date:  2012-07       Impact factor: 34.870

4.  Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.

Authors:  David J Bonda; Maneesh Mailankot; Jeremy G Stone; Matthew R Garrett; Magdalena Staniszewska; Rudy J Castellani; Sandra L Siedlak; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Ram H Nagaraj; Mark A Smith
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 5.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

6.  The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.

Authors:  Marieke C Wichers; Michael Maes
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

7.  HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.

Authors:  Rémi Planès; Elmostafa Bahraoui
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 8.  Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 9.  Redox Properties of Tryptophan Metabolism and the Concept of Tryptophan Use in Pregnancy.

Authors:  Kang Xu; Hongnan Liu; Miaomiao Bai; Jing Gao; Xin Wu; Yulong Yin
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

Review 10.  The common inflammatory etiology of depression and cognitive impairment: a therapeutic target.

Authors:  David J Allison; David S Ditor
Journal:  J Neuroinflammation       Date:  2014-09-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.